Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

forbes.com - Harini Gopalakrishnan - ​Pharma's AI Inflection Point: Five Lessons For CAIOs
​Pharma's AI Inflection Point: Five Lessons For CAIOs
Forbes

Harini Gopalakrishnan, Founder of theHaze.ai & Industry GTM, Vespa,ai. AI companies are entering the life science services fray. Anthropic's recent launch of Claude Science is a good example of that shift, positioning an AI company not only as a…

marketwatch.com - Fuji Pharma 9-Mos Net Y1.82B Vs Net Y1.83B
Fuji Pharma 9-Mos Net Y1.82B Vs Net Y1.83B
MarketWatch

Fuji Pharma Co. Ltd. (4554.TO) Japan Nine Months Ended June 30 GROUP 2026 2025 Revenue Y45.38 bln Y36.95 bln Operating Profit Y5.39 bln Y3.37 bln Pretax Profit Y5.48 bln Y3.16 bln Net Profit Y1.82 bln Y1.83 bln Per share Earnings Y72.11 Y75.07…

globenewswire.com - Zealand Pharma - Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results
Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results
GlobeNewswire

Press Release – No. 14 / 2026 Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results Copenhagen, Denmark, August 6, 2026 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no.

cnbc.com - Elsa Ohlen - AstraZeneca may buck a decade of pharma strategy to buy U.S. scale
AstraZeneca may buck a decade of pharma strategy to buy U.S. scale
CNBC

Reported talks of a tie-up between two industry giants could deliver instant U.S. scale for AstraZeneca through Bristol Myers Squibb's U.S.-centric business, but at the cost of slower growth and integration risk. The reports had the industry…

marketbeat.com - Royalty Pharma Q2 Earnings Call Highlights
Royalty Pharma Q2 Earnings Call Highlights
MarketBeat

How Royalty Pharma Prints Cash Without Biotech's Biggest Risks Royalty Pharma NASDAQ: RPRX raised its 2026 outlook for the second consecutive quarter after reporting higher second-quarter royalty receipts, continued capital deployment and progress…

marketbeat.com - HC Wainwright Boosts Earnings Estimates for Nuvectis Pharma
HC Wainwright Boosts Earnings Estimates for Nuvectis Pharma
MarketBeat

Nuvectis Pharma, Inc. (NASDAQ:NVCT - Free Report) - HC Wainwright boosted their Q3 2026 earnings per share (EPS) estimates for Nuvectis Pharma in a note issued to investors on Tuesday, August 4th. HC Wainwright analyst J. Pantginis now forecasts…

marketbeat.com - Zealand Pharma A/S (ZLDPF) Projected to Post Earnings on Thursday
Zealand Pharma A/S (ZLDPF) Projected to Post Earnings on Thursday
MarketBeat

Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) will likely be announcing its results before the market opens on Thursday, August 13th. Analysts expect the company to post earnings of $0.1431 per share and revenue of $128.9080 million for the…

marketbeat.com - Zealand Pharma A/S (OTCMKTS:ZLDPF) Given Consensus Rating of 'Hold' by Analysts
Zealand Pharma A/S (OTCMKTS:ZLDPF) Given Consensus Rating of 'Hold' by Analysts
MarketBeat

Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) has been given a consensus rating of 'Hold' by the nine ratings firms that are presently covering the company, MarketBeat Ratings reports. Eight investment analysts have rated the stock with a…

marketbeat.com - Royalty Pharma (NASDAQ:RPRX) Announces Earnings Results, Misses Expectations By $1.23 EPS
Royalty Pharma (NASDAQ:RPRX) Announces Earnings Results, Misses Expectations By $1.23 EPS
MarketBeat

Royalty Pharma (NASDAQ:RPRX - Get Free Report) issued its earnings results on Wednesday. The biopharmaceutical company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.27 by ($1.23), FiscalAI reports.

marketbeat.com - Bank of America Corp DE Buys 786,921 Shares of Royalty Pharma PLC $RPRX
Bank of America Corp DE Buys 786,921 Shares of Royalty Pharma PLC $RPRX
MarketBeat

Bank of America Corp DE grew its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 29.0% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,495,846 shares…

marketbeat.com - Urogen Pharma (NASDAQ:URGN) Hits New 1-Year High - What's Next?
Urogen Pharma (NASDAQ:URGN) Hits New 1-Year High - What's Next?
MarketBeat

Urogen Pharma (NASDAQ:URGN - Get Free Report) hit a new 52-week high during mid-day trading on Thursday. The stock traded as high as $47.84 and last traded at $46.43, with a volume of 2480596 shares. The stock had previously closed at $39.92. 3…

marketbeat.com - Urogen Pharma (NASDAQ:URGN) Given New $75.00 Price Target at HC Wainwright
Urogen Pharma (NASDAQ:URGN) Given New $75.00 Price Target at HC Wainwright
MarketBeat

Urogen Pharma (NASDAQ:URGN - Get Free Report) had its price objective raised by investment analysts at HC Wainwright from $45.00 to $75.00 in a report issued on Thursday, Marketbeat.com reports. The firm currently has a 'buy' rating on the stock.

thehindubusinessline.com - Stocks to watch, Aug 6: Oil India, Infosys, NBCC, Zee, Cohance Life, Gland Pharma, Neuland Lab, Monarch Surveyors, RMC Switchgears
Stocks to watch, Aug 6: Oil India, Infosys, NBCC, Zee, Cohance Life, Gland Pharma, Neuland Lab, Monarch Surveyors, RMC Switchgears
BusinessLine

Metsä Group has chosen Infosys, a global leader in AI-first business consulting and technology services, as its partner to modernize its IT environment. The selection was made following a comprehensive tendering and negotiation process. The…

thehindubusinessline.com - KS Badri Narayanan - Q1 Results 06th Aug Live: Trent, Hero MotoCorp, Lupin, Britannia, Siemens Energy, LIC, BOSCH, Kirloskar Oil Engines, Aegis Logistics, Premier Energies, Emcure Pharma to announce Q1 results, Biocon, Berger Paints, Neuland Lab, ArisInfra gain, Aurobindo Pharma, Aster DM, Whirlpool, PB Fintech, Power G
Q1 Results 06th Aug Live: Trent, Hero MotoCorp, Lupin, Britannia, Siemens Energy, LIC, BOSCH, Kirloskar Oil Engines, Aegis Logistics, Premier Energies, Emcure Pharma to announce Q1 results, Biocon, Berger Paints, Neuland Lab, ArisInfra gain, Aurobindo Pharma, Aster DM, Whirlpool, PB Fintech, Power G
BusinessLine

Q1 Results Today, 06th August 2026 Live Updates: Find all the latest Q1 results 2026 updates of Allied Digital Services, Advance Agrolife, Advent Hotels International, Aegis Logistics, Ambassador Intra Holdings, Albert David, Alfred Herbert India…

marketbeat.com - Urogen Pharma (NASDAQ:URGN) Announces Quarterly Earnings Results, Misses Estimates By $0.02 EPS
Urogen Pharma (NASDAQ:URGN) Announces Quarterly Earnings Results, Misses Estimates By $0.02 EPS
MarketBeat

Urogen Pharma (NASDAQ:URGN - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.26) by ($0.02), FiscalAI reports. The…

Receive a Daily briefing on Pharma Industry News

Get Started